Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Sell
12,239
-3,971
-24% -$1.1M 0.03% 472
2025
Q4
$4.46M Buy
16,210
+7,230
+81% +$2.03M 0.04% 359
2025
Q3
$2.59M Buy
8,980
+560
+7% +$166K 0.02% 485
2025
Q2
$2.78M Sell
8,420
-2,607
-24% -$840K 0.03% 415
2025
Q1
$3.63M Sell
11,027
-6,343
-37% -$1.91M 0.05% 302
2024
Q4
$4.8M Buy
17,370
+11,883
+217% +$3.79M 0.08% 215
2024
Q3
$1.9M Sell
5,487
-10,255
-65% -$3.53M 0.05% 400
2024
Q2
$5.2M Sell
15,742
-77,829
-83% -$26.8M 0.14% 135
2024
Q1
$34M Buy
93,571
+18,222
+24% +$6M 0.71% 18
2023
Q4
$22.6M Buy
75,349
+10,881
+17% +$3.18M 0.57% 26
2023
Q3
$18.4M Buy
+64,468
New +$18.4M 0.57% 27

Other funds holding CI

Vident Advisory's CI Position: Q1 2026 in Review

Vident Advisory reduced its Cigna (CI) stake by 24% in Q1 2026, selling an estimated $1.1M and leaving 12,239 shares worth $3.26M. The position accounts for 0.03% of the portfolio, ranked #472.

Vident Advisory first reported a position in CI in Q3 2023 and has held it in 11 quarters since. The position peaked at $34M in Q1 2024. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Vident Advisory held 12,239 shares of Cigna worth $3.26M as of Q1 2026.
  • Vident Advisory sold 3,971 Cigna shares in Q1 2026, an estimated $1.1M.
  • Cigna made up 0.03% of Vident Advisory's portfolio in Q1 2026, its #472 holding.
  • Vident Advisory first reported a position in Cigna in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Cigna position peaked at $34M in Q1 2024.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.